182 related articles for article (PubMed ID: 30365139)
1. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
Huang Y; Zou Y; Lin L; Ma X; Zheng R
Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139
[TBL] [Abstract][Full Text] [Related]
2. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
3. MiR-16 inhibits pituitary adenoma cell proliferation via the suppression of ERK/MAPK signal pathway.
Wang DW; Wang YQ; Shu HS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1241-1248. PubMed ID: 29565480
[TBL] [Abstract][Full Text] [Related]
4. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance.
Chen LZ; Ding Z; Zhang Y; He ST; Wang XH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3734-3741. PubMed ID: 29949147
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑125a‑5p controls the proliferation, apoptosis, migration and PTEN/MEK1/2/ERK1/2 signaling pathway in MCF‑7 breast cancer cells.
Liang Z; Pan Q; Zhang Z; Huang C; Yan Z; Zhang Y; Li J
Mol Med Rep; 2019 Nov; 20(5):4507-4514. PubMed ID: 31702027
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
8. Effects of Erythromycin on the Proliferation and Apoptosis of Cultured Nasal Polyp-Derived Cells and the Extracellular Signal-Regulated Kinase (ERK)/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.
Liu X; Wang X; Chen L; Shi Y; Wei Y
Med Sci Monit; 2018 Nov; 24():8048-8055. PubMed ID: 30414267
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
10. miR-181a down-regulates MAP2K1 to enhance adriamycin sensitivity in leukemia HL-60 cells.
Wang JJ; Yu JP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2497-2504. PubMed ID: 30964176
[TBL] [Abstract][Full Text] [Related]
11. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3333-3341. PubMed ID: 29917183
[TBL] [Abstract][Full Text] [Related]
12. MiR-145-modulated SOX9-mediated hypospadias through acting on mitogen-activated protein kinase signaling pathway.
Shang Y; Kang Y; Sun J; Wei P; Yang J; Zhang H
J Cell Physiol; 2019 Jul; 234(7):10397-10410. PubMed ID: 30565690
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Activation of Mitogen-Activated Protein Kinase (MAPK)/Extracellular Signal-Regulated Kinase (ERK) Signaling Pathway in Proliferation of Urethral Plate Fibroblasts in Finasteride-Induced Rat Hypospadias.
An N; Peng J; He G; Fan X; Li F; Chen H
Med Sci Monit; 2018 Dec; 24():8984-8992. PubMed ID: 30538214
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-497 suppress osteosarcoma by targeting MAPK/Erk pathway.
Gui ZL; Wu TL; Zhao GC; Lin ZX; Xu HG
Bratisl Lek Listy; 2017; 118(8):449-452. PubMed ID: 29050481
[TBL] [Abstract][Full Text] [Related]
15. miR-16 regulates proliferation and invasion of lung cancer cells via the ERK/MAPK signaling pathway by targeted inhibition of MAPK kinase 1 (MEK1).
Chen T; Xiao Q; Wang X; Wang Z; Hu J; Zhang Z; Gong Z; Chen S
J Int Med Res; 2019 Oct; 47(10):5194-5204. PubMed ID: 31379227
[TBL] [Abstract][Full Text] [Related]
16. hsa‑miR‑429 targets CBX8 to promote cell apoptosis in diffuse large B‑cell lymphoma.
Liang Y; Yu ZJ; Liu M; Liu HM; Zhang JZ; Xiong T; Tang YY; Huang ZP
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651663
[TBL] [Abstract][Full Text] [Related]
17. [Estradiol activates MAPK signaling pathway by estrogen induced VEGF and bFGF in endometrial cancer cells].
Lu Y; Jiang S; Zhang J; Song H; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):925-31. PubMed ID: 25608994
[TBL] [Abstract][Full Text] [Related]
18. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
[TBL] [Abstract][Full Text] [Related]
19. microRNA‑196a‑3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large B‑cell lymphoma.
Fu J; Lou X; Wan S; Zhao X; Chen Z; Zhu M; Guo L; Wu D; Wang S
Oncol Rep; 2021 Feb; 45(2):764-775. PubMed ID: 33416178
[TBL] [Abstract][Full Text] [Related]
20. Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway.
Cui J; Guo R; Wang Y; Song Y; Song X; Li H; Song X; Li J
Bioengineered; 2022 Feb; 13(2):4428-4440. PubMed ID: 35139768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
